SMA SOLAR TECHNOLOGY AG (S92.DE)

DE000A0DJ6J9 - Common Stock

15.86  +0.95 (+6.37%)

Fundamental Rating

4

Overall S92 gets a fundamental rating of 4 out of 10. We evaluated S92 against 53 industry peers in the Semiconductors & Semiconductor Equipment industry. S92 has an average financial health and profitability rating. S92 is valued correctly, but it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

S92 had positive earnings in the past year.
In the past year S92 has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: S92 reported negative net income in multiple years.
In multiple years S92 reported negative operating cash flow during the last 5 years.

1.2 Ratios

S92 has a better Return On Assets (14.50%) than 67.92% of its industry peers.
With a decent Return On Equity value of 34.04%, S92 is doing good in the industry, outperforming 73.58% of the companies in the same industry.
The Return On Invested Capital of S92 (24.57%) is better than 84.91% of its industry peers.
Industry RankSector Rank
ROA 14.5%
ROE 34.04%
ROIC 24.57%
ROA(3y)5.58%
ROA(5y)3.73%
ROE(3y)13.08%
ROE(5y)8.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 9.96%, S92 is not doing good in the industry: 66.04% of the companies in the same industry are doing better.
S92's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 11.93%, S92 is not doing good in the industry: 71.70% of the companies in the same industry are doing better.
S92 has a worse Gross Margin (28.20%) than 90.57% of its industry peers.
S92's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.93%
PM (TTM) 9.96%
GM 28.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y63.01%
PM growth 5YN/A
GM growth 3Y21.83%
GM growth 5Y17.09%

4

2. Health

2.1 Basic Checks

S92 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for S92 remains at a similar level compared to 1 year ago.
The number of shares outstanding for S92 remains at a similar level compared to 5 years ago.
S92 has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.20 indicates that S92 is not in any danger for bankruptcy at the moment.
The Altman-Z score of S92 (3.20) is worse than 60.38% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that S92 is not too dependend on debt financing.
S92 has a better Debt to Equity ratio (0.03) than 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.2
ROIC/WACC2.08
WACC11.8%

2.3 Liquidity

S92 has a Current Ratio of 1.77. This is a normal value and indicates that S92 is financially healthy and should not expect problems in meeting its short term obligations.
S92 has a Current ratio of 1.77. This is in the lower half of the industry: S92 underperforms 66.04% of its industry peers.
S92 has a Quick Ratio of 1.77. This is a bad value and indicates that S92 is not financially healthy enough and could expect problems in meeting its short term obligations.
S92 has a Quick ratio of 0.74. This is amonst the worse of the industry: S92 underperforms 86.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.74

3

3. Growth

3.1 Past

S92 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.56%.
S92 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 100.21% yearly.
S92 shows a decrease in Revenue. In the last year, the revenue decreased by -4.95%.
The Revenue has been growing by 20.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-64.56%
EPS 3Y100.21%
EPS 5YN/A
EPS Q2Q%-112.16%
Revenue 1Y (TTM)-4.95%
Revenue growth 3Y22.87%
Revenue growth 5Y20.13%
Sales Q2Q%-46.21%

3.2 Future

S92 is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.84% yearly.
The Revenue is expected to decrease by -3.38% on average over the next years.
EPS Next Y-86.61%
EPS Next 2Y-54.1%
EPS Next 3Y-32.38%
EPS Next 5Y-6.84%
Revenue Next Year-16.71%
Revenue Next 2Y-8.68%
Revenue Next 3Y-2.73%
Revenue Next 5Y-3.38%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.90, the valuation of S92 can be described as very cheap.
Based on the Price/Earnings ratio, S92 is valued cheaper than 98.11% of the companies in the same industry.
S92 is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.58 indicates a reasonable valuation of S92.
Based on the Price/Forward Earnings ratio, S92 is valued a bit cheaper than 79.25% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.67, S92 is valued rather cheaply.
Industry RankSector Rank
PE 6.9
Fwd PE 11.58

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, S92 is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.46

4.3 Compensation for Growth

A cheap valuation may be justified as S92's earnings are expected to decrease with -32.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.1%
EPS Next 3Y-32.38%

4

5. Dividend

5.1 Amount

S92 has a Yearly Dividend Yield of 3.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.38, S92 pays a better dividend. On top of this S92 pays more dividend than 98.11% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, S92 pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y-54.1%
EPS Next 3Y-32.38%

SMA SOLAR TECHNOLOGY AG

FRA:S92 (1/6/2025, 7:00:00 PM)

15.86

+0.95 (+6.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners36.41%
Inst Owner ChangeN/A
Ins Owners21.32%
Ins Owner ChangeN/A
Market Cap550.34M
Analysts49.23
Price Target14.43 (-9.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)32.3%
Min EPS beat(2)-28.28%
Max EPS beat(2)92.88%
EPS beat(4)1
Avg EPS beat(4)9.27%
Min EPS beat(4)-28.28%
Max EPS beat(4)92.88%
EPS beat(8)5
Avg EPS beat(8)97.24%
EPS beat(12)8
Avg EPS beat(12)80.37%
EPS beat(16)10
Avg EPS beat(16)76.65%
Revenue beat(2)1
Avg Revenue beat(2)-5.8%
Min Revenue beat(2)-15.17%
Max Revenue beat(2)3.57%
Revenue beat(4)2
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-15.17%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)8.21%
Revenue beat(12)7
Avg Revenue beat(12)22.92%
Revenue beat(16)8
Avg Revenue beat(16)16.2%
PT rev (1m)-5.71%
PT rev (3m)-49.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.51%
Valuation
Industry RankSector Rank
PE 6.9
Fwd PE 11.58
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.94
EV/EBITDA 1.46
EPS(TTM)2.3
EY14.5%
EPS(NY)1.37
Fwd EY8.63%
FCF(TTM)-7.06
FCFYN/A
OCF(TTM)-4.2
OCFYN/A
SpS70.4
BVpS20.59
TBVpS16.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.5%
ROE 34.04%
ROCE 29.45%
ROIC 24.57%
ROICexc 29.54%
ROICexgc 35.1%
OM 11.93%
PM (TTM) 9.96%
GM 28.2%
FCFM N/A
ROA(3y)5.58%
ROA(5y)3.73%
ROE(3y)13.08%
ROE(5y)8.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y63.01%
PM growth 5YN/A
GM growth 3Y21.83%
GM growth 5Y17.09%
F-Score5
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr 213.41%
Cap/Sales 4.07%
Interest Coverage 175.51
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 0.74
Altman-Z 3.2
F-Score5
WACC11.8%
ROIC/WACC2.08
Cap/Depr(3y)159.88%
Cap/Depr(5y)125.72%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.56%
EPS 3Y100.21%
EPS 5YN/A
EPS Q2Q%-112.16%
EPS Next Y-86.61%
EPS Next 2Y-54.1%
EPS Next 3Y-32.38%
EPS Next 5Y-6.84%
Revenue 1Y (TTM)-4.95%
Revenue growth 3Y22.87%
Revenue growth 5Y20.13%
Sales Q2Q%-46.21%
Revenue Next Year-16.71%
Revenue Next 2Y-8.68%
Revenue Next 3Y-2.73%
Revenue Next 5Y-3.38%
EBIT growth 1Y29.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89.89%
EBIT Next 3Y-16.67%
EBIT Next 5Y-16.18%
FCF growth 1Y-2161.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-313.72%
OCF growth 3YN/A
OCF growth 5YN/A